In resected #AcralMelanoma, this multicenter retrospective study found adjuvant anti‑PD‑1 therapy achieved RFS comparable to high‑dose interferon, with substantially fewer grade 3–4 toxicities. KIT‑mutant disease showed a signal of greater benefit. Ther Adv Med Oncol
buff.ly/QukRAI9
#Immunotherapy
